Natera, Inc. (NTRA) stock
NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30138% above fair value
$287.47−1.01 (-0.35%)
Close on Nov 17, 2026Market cap $41.44BP/E –Yield –
Natera total assets
Total assets on the balance sheet at the end of each period.
Natera's total assets was $2.66B at Jun 30, 2026. For fiscal 2025 it was $2.40B, up 44.4% from the year before. Over ten years it grew 24.6% a year on average. The highest annual figure on record is $2.40B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.40B | +44.4% |
| FY2024 | Dec 31, 2024 | $1.66B | +15.2% |
| FY2023 | Dec 31, 2023 | $1.44B | +3.4% |
| FY2022 | Dec 31, 2022 | $1.39B | +12.8% |
| FY2021 | Dec 31, 2021 | $1.24B | +32.6% |
| FY2020 | Dec 31, 2020 | $932.15M | +60.0% |
| FY2019 | Dec 31, 2019 | $582.66M | +117.3% |
| FY2018 | Dec 31, 2018 | $268.17M | +25.0% |
| FY2017 | Dec 31, 2017 | $214.61M | +1.9% |
| FY2016 | Dec 31, 2016 | $210.68M | -20.6% |
| FY2015 | Dec 31, 2015 | $265.24M | +114.6% |
| FY2014 | Dec 31, 2014 | $123.62M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.66B | +51.2% |
| Q1 FY2026 | Mar 31, 2026 | $2.61B | +50.9% |
| Q4 FY2025 | Dec 31, 2025 | $2.40B | +44.4% |
| Q3 FY2025 | Sep 30, 2025 | $1.82B | +14.5% |
| Q2 FY2025 | Jun 30, 2025 | $1.76B | +15.8% |
| Q1 FY2025 | Mar 31, 2025 | $1.73B | +18.0% |
| Q4 FY2024 | Dec 31, 2024 | $1.66B | +15.2% |
| Q3 FY2024 | Sep 30, 2024 | $1.59B | +10.0% |
| Q2 FY2024 | Jun 30, 2024 | $1.52B | +21.6% |
| Q1 FY2024 | Mar 31, 2024 | $1.47B | +11.3% |
| Q4 FY2023 | Dec 31, 2023 | $1.44B | +3.4% |
| Q3 FY2023 | Sep 30, 2023 | $1.45B | +43.3% |
| Q2 FY2023 | Jun 30, 2023 | $1.25B | +17.0% |
| Q1 FY2023 | Mar 31, 2023 | $1.32B | +15.2% |
| Q4 FY2022 | Dec 31, 2022 | $1.39B | +12.8% |
| Q3 FY2022 | Sep 30, 2022 | $1.01B | -23.0% |
| Q2 FY2022 | Jun 30, 2022 | $1.07B | +25.5% |
| Q1 FY2022 | Mar 31, 2022 | $1.14B | +28.1% |
| Q4 FY2021 | Dec 31, 2021 | $1.24B | +32.6% |
| Q3 FY2021 | Sep 30, 2021 | $1.31B | +34.3% |
| Q2 FY2021 | Jun 30, 2021 | $849.96M | +17.5% |
| Q1 FY2021 | Mar 31, 2021 | $893.51M | +59.9% |
| Q4 FY2020 | Dec 31, 2020 | $932.15M | +60.0% |
| Q3 FY2020 | Sep 30, 2020 | $976.71M | +156.9% |
| Q2 FY2020 | Jun 30, 2020 | $723.26M | +88.7% |
| Q1 FY2020 | Mar 31, 2020 | $558.64M | +113.7% |
| Q4 FY2019 | Dec 31, 2019 | $582.66M | +117.3% |
| Q3 FY2019 | Sep 30, 2019 | $380.25M | +37.1% |
| Q2 FY2019 | Jun 30, 2019 | $383.33M | +97.2% |
| Q1 FY2019 | Mar 31, 2019 | $261.45M | +19.6% |
| Q4 FY2018 | Dec 31, 2018 | $268.17M | +25.0% |
| Q3 FY2018 | Sep 30, 2018 | $277.31M | +35.9% |
| Q2 FY2018 | Jun 30, 2018 | $194.36M | +22.7% |
| Q1 FY2018 | Mar 31, 2018 | $218.66M | +24.2% |
| Q4 FY2017 | Dec 31, 2017 | $214.61M | +1.9% |
| Q3 FY2017 | Sep 30, 2017 | $204.06M | -15.8% |
| Q2 FY2017 | Jun 30, 2017 | $158.43M | – |
| Q1 FY2017 | Mar 31, 2017 | $176.02M | – |
| Q4 FY2016 | Dec 31, 2016 | $210.68M | – |
| Q3 FY2016 | Sep 30, 2016 | $242.39M | – |
See a number that looks wrong?